Skip to main content
. 2021 Mar 30;204(10):e97–e109. doi: 10.1164/rccm.202109-2093ST

Table 1.

Questions Initially Proposed by the Guideline Co-Chairs and Question Selection Results

Proposed Question Priority*
Should patients with asthma in whom treatment is being contemplated undergo FeNO testing? 10
Should patients being treated for asthma undergo FeNO monitoring? 4
Should patients in whom a diagnosis of asthma is being considered undergo FeNO testing? 3

Definition of abbreviation: FeNO = fractional exhaled nitric oxide.

*

Number of panel members who selected this question as the highest priority.